SCHEMBL2848332

SCHEMBL2848332

C=CCc1ccc(OC)cc1OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
ALOX15 P16050 1/20 0.47
ALOX12 P18054 1/20 0.47
LMNA P02545 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPT P10636 1/20 0.45
KDM4E B2RXH2 1/20 0.44
PTPN1 P18031 1/20 0.44
APLNR P35414 1/20 0.44
GAA P10253 1/20 0.43
CREBBP Q92793 1/20 0.43
GABRA1 P14867 2/20 0.42
GABRB2 P47870 2/20 0.42
SLC2A1 P11166 1/20 0.41
ESR1 P03372 2/20 0.41
AHR P35869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2846105 0.90 KDM4E (0.50) TSHRSMN1; SMN2ALDH1A1TP53CYP3A4
SCHEMBL2845272 0.88 MAPT (0.49) TSHRSMN1; SMN2ALDH1A1TP53CYP3A4
SCHEMBL2844258 0.88 CNR2 (0.50) TSHRSMN1; SMN2ALDH1A1TP53CYP3A4
SCHEMBL2841579 0.87 PTPN1 (0.49) TSHRSMN1; SMN2ALDH1A1TP53CYP3A4
SCHEMBL2842624 0.87 FLT3 (0.51) TSHRSMN1; SMN2ALDH1A1TP53CYP3A4
SCHEMBL30105464 0.86 APLNR (0.58) TSHRSMN1; SMN2ALDH1A1TP53CYP3A4
SCHEMBL2845262 0.86 APLNR (0.58) TSHRSMN1; SMN2ALDH1A1TP53CYP3A4
SCHEMBL2846450 0.84 KDM4E (0.46) ALDH1A1LMNAL3MBTL1MAPTKDM4E
SCHEMBL2849927 0.84 CNR2 (0.47) TSHRALDH1A1LMNAL3MBTL1MAPT
SCHEMBL2842114 0.83 KDM4E (0.43) TSHRSMN1; SMN2ALDH1A1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130131185-A1 Methods and Compositions for Control of Cabbage Looper, Trichoplusia ni THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-05-23 US claimed
US-9497963-B2 Methods and compositions for control of gypsy moth, Lymantria dispar SIMON FRASER UNIVERSITY (CA) 2016-11-22 US disclosed
US-9125406-B2 Methods and compositions for control of cabbage looper, trichoplusia ni SIMON FRASER UNIVERSITY (CA) 2015-09-08 US disclosed
US-20130131185-A1 Methods and Compositions for Control of Cabbage Looper, Trichoplusia ni THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-05-23 US disclosed
US-20130045178-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTH, Lymantria dispar SIMON FRASER UNIVERSITY (CA) 2013-02-21 US disclosed
US-20100297059-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, LYMANRIA DISPAR SIMON FRASER UNIVERSITY (CA) 2010-11-25 US disclosed
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar SIMON FRASER UNIVERSITY (CA) 2010-07-29 US disclosed
US-20100160451-A1 METHODS AND COMPOSITIONS FOR CONTROL OF CABBAGE LOOPER, Trichoplusia ni SIMON FRASER UNIVERSITY (CA) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131185-A1 Methods and Compositions for Control of Cabbage Looper, Trichoplusia ni CDV3, ETV1, BOLA2; BOLA2B TSHR 1738/4885SMN1; SMN2 3587/4885ALDH1A1 2318/4885
US-20130045178-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTH, Lymantria dispar L3MBTL3, L3MBTL4, L3MBTL1 TSHR 3192/4885SMN1; SMN2 3731/4885ALDH1A1 4074/4885
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar L3MBTL3, L3MBTL4, L3MBTL1 TSHR 3461/4885SMN1; SMN2 3962/4885ALDH1A1 4132/4885
US-20100160451-A1 METHODS AND COMPOSITIONS FOR CONTROL OF CABBAGE LOOPER, Trichoplusia ni CDV3, ETV1, TMSB4X TSHR 1753/4885SMN1; SMN2 3616/4885ALDH1A1 2444/4885
US-20100297059-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, LYMANRIA DISPAR L3MBTL3, L3MBTL4, L3MBTL1 TSHR 3431/4885SMN1; SMN2 3957/4885ALDH1A1 4180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.